| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507908 | Acta Pharmaceutica Sinica B | 2018 | 9 Pages |
Abstract
Nanoparticles can be cloaked with various types of cell membranes. The membrane-coating technology can prolong the circulation of nanomedicine in the bloodstream and show cancer-targeting potential by molecular recognition. This review provides an overview of cell membrane-based nanoparticles (CMBNPs) for tumor diagnosis and treatment.314
Keywords
VCAM1PTXRBCDSPETDDsTargeting drug delivery systemBiomimetic nanoparticleICGNIRDOXCTCPLGANPsIndocyanine greenDrug deliverymolecular recognitionEPRcirculationDoxorubicinCancer cellCell membraneTRAILtumor necrosis factor-related apoptosis inducing ligandNear infraredvascular cell adhesion molecule-1NanoparticlesEnhanced permeability and retentionCancer targetingPaclitaxelPoly (lactic-co-glycolic acid)circulating tumor cellred blood cell
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Ruixiang Li, Yuwei He, Shuya Zhang, Jing Qin, Jianxin Wang,